Press Releases Year None202120202019201820172016 Gamida Cell to Present at the 20th Annual Needham Virtual Healthcare Conference April 7, 2021 PDF Version View HTML Gamida Cell Presents Efficacy and Safety Results of Phase 3 Study of Omidubicel in Patients with Hematologic Malignancies at the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) March 15, 2021 PDF Version View HTML Gamida Cell Reports Full Year 2020 Financial Results and Provides Company Update March 9, 2021 PDF Version View HTML Gamida Cell to Present at Upcoming Investor Conferences March 3, 2021 PDF Version View HTML Gamida Cell Announces the Date of Its Full Year 2020 Financial Results and Webcast March 2, 2021 PDF Version View HTML Gamida Cell Announces Results from Phase 3 Study of Omidubicel to be Presented at the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) March 1, 2021 PDF Version View HTML Gamida Cell Announces $75 Million Financing with Highbridge Capital Management February 16, 2021 PDF Version View HTML Gamida Cell Presents Efficacy and Safety Results of Phase 3 Study of Omidubicel in Patients with Hematologic Malignancies at the 2021 TCT Meetings of ASTCT and CIBMTR February 9, 2021 PDF Version View HTML Gamida Cell to Present Full Data from Phase 3 Study of Omidubicel at TCT, the Combined Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR January 11, 2021 PDF Version View HTML Gamida Cell to Present at Upcoming January Investor Conferences January 5, 2021 PDF Version View HTML
